China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Telesurgery versus Local Surgery in Low-Risk Hepatectomy: A Non-inferiority Randomized ... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Association Between GIS-Based Food Environment and Dental Caries in Adolescents: A ... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A clinical study using machine learning methods based on multimodal brain imaging to ev... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Status and Influencing Factors of Benefit Finding in Patients with Allergi... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Influence of Nutritional Risk on Postoperative Complications in Elderly Pa... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of clinical effect of eating bird's nest on relieving female climacteric syn... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploratory development of a diagnostic model for insomnia combined with mild cognitive... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Application and Promotion of Multimodal Integrated Fusion Precision Localization Te... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multicenter Study on the Feasibility of 18F-FDG Total-body PET/CT Imaging at 6 Hours'. ... और पढ़ें
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxoru... और पढ़ें